Advice
Recommended for general use within NHS Scotland.
RECOMMENDATION Vardenafil represents an acceptable alternative to other phosphodiesterase type 5 inhibitors for erectile dysfunction.
This drug is likely to be subject to the same NHS prescribing restrictions as other drug treatments for erectile dysfunction in terms of Schedule 11 of the National Health Service (General Medical Services) (Scotland) Regulations 1995.
Download detailed advice21KB (PDF)
Medicine details
- Medicine name:
- Vardenafil (Levitra®)
- SMC ID:
- 47/03
- Indication:
- Erectile dysfunction
- Pharmaceutical company
- GlaxoSmithKline UK Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Status
- Accepted
- Date advice published
- 06 June 2003